We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+2.24%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.51B
AUM Growth
-$82.4M
Cap. Flow
-$100M
Cap. Flow %
-4%
Top 10 Hldgs %
22.43%
Holding
1,530
New
76
Increased
658
Reduced
739
Closed
53

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$7.83M
2
DD icon
DuPont de Nemours
DD
+$6.5M
3
ABBV icon
AbbVie
ABBV
+$5.98M
4
CELG
Celgene Corp
CELG
+$3.68M
5
NFLX icon
Netflix
NFLX
+$3.26M

Sector Composition

Rank Sector Weight
1 Technology 26.5%
2 Healthcare 18.58%
3 Financials 10.77%
4 Communication Services 10.27%
5 Consumer Discretionary 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JUNO
1526
DELISTED
Juno Therapeutics, Inc.
JUNO
-31,805
Closed -$1.45M
CAA
1527
DELISTED
CalAtlantic Group, Inc.
CAA
-8,823
Closed -$498K
BWLD
1528
DELISTED
Buffalo Wild Wings, Inc.
BWLD
-1,753
Closed -$274K
TIME
1529
DELISTED
Time Inc.
TIME
-17,537
Closed -$324K
DOC
1530
DELISTED
PHYSICIANS REALTY TRUST
DOC
-11,123
Closed -$200K

Similar funds

Profund Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Profund Advisors held 1,530 positions worth $2.51B, down 3.2% from $2.59B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Profund Advisors withdrew a net $100M in Q1 2018, closing 53 positions and reducing 739 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $2.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Profund Advisors opened a new position in Okta worth $1.55M.

  • Profund Advisors's largest Q1 2018 buy was Okta: 38,807 shares worth $1.55M.
  • Profund Advisors added most to Agilent Technologies in Q1 2018, an estimated $7.07M increase.
  • Profund Advisors's biggest Q1 2018 reduction was Amgen, cutting an estimated $7.83M.
  • Profund Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $2.76M.
  • Profund Advisors's ten largest holdings make up 22% of its $2.51B portfolio in Q1 2018.
  • Profund Advisors opened 76 new positions and closed 53 in Q1 2018.
  • Profund Advisors's portfolio value fell 3.2% quarter-over-quarter to $2.51B.

Based on Profund Advisors's 13F filing for Q1 2018, filed 14 May 2018.